Ce se schimbă după preluarea Biofarm de către Polpharma. Planuri pentru medicamente, producție și angajări

Biofarm, a major Romanian pharmaceutical producer, has been acquired by Polpharma Group for approximately €257 million. The acquisition has been finalized with all necessary approvals. Polpharma aims to expand its presence in Romania, leveraging Biofarm's established market position. The integration is expected to enhance production capacity and open new export opportunities. Officials assure that there will be no significant price changes for medications due to the acquisition. Both companies emphasize long-term growth strategies and the potential for Biofarm products to reach new international markets.